BR112022019616A2 - Compostos terpenofenólicos e seu uso - Google Patents

Compostos terpenofenólicos e seu uso

Info

Publication number
BR112022019616A2
BR112022019616A2 BR112022019616A BR112022019616A BR112022019616A2 BR 112022019616 A2 BR112022019616 A2 BR 112022019616A2 BR 112022019616 A BR112022019616 A BR 112022019616A BR 112022019616 A BR112022019616 A BR 112022019616A BR 112022019616 A2 BR112022019616 A2 BR 112022019616A2
Authority
BR
Brazil
Prior art keywords
compounds
cbd
ene
tetrahydro
prop
Prior art date
Application number
BR112022019616A
Other languages
English (en)
Inventor
George Stott Colin
R Heap Charles
Gurusankar Ramamoorthy
Original Assignee
Phytotherapeutix Ltd
Alinova Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotherapeutix Ltd, Alinova Biosciences Ltd filed Critical Phytotherapeutix Ltd
Publication of BR112022019616A2 publication Critical patent/BR112022019616A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

COMPOSTOS TERPENOFENÓLICOS E SEU USO. A presente divulgação descreve compostos terpenofenólicos e seu uso na medicina. A presente divulgação descreve ainda compostos do tipo perrotetineno, sua fabricação, formulações contendo os mesmos e seu uso na medicina. Tais compostos incluem (1'R,2'R)-5'-metil-fenetil-2'-(prop-1-eno-2-il)-1',2',3',4'-tetra-hidro-[1,1'-bifenil]- 2,6-diol (CBD-PET) ou (1'R,2'R)-4-(4-hidroxifenetil)-5'-metil-2'-(prop-1-eno-2-il)- 1',2',3',4'-tetra-hidro-[1,1'-bifenil]-2,6-diol (CBD-PET-OH).
BR112022019616A 2020-03-31 2021-03-31 Compostos terpenofenólicos e seu uso BR112022019616A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (1)

Publication Number Publication Date
BR112022019616A2 true BR112022019616A2 (pt) 2022-12-06

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019616A BR112022019616A2 (pt) 2020-03-31 2021-03-31 Compostos terpenofenólicos e seu uso

Country Status (12)

Country Link
US (2) US20230227390A1 (pt)
EP (1) EP4126800A1 (pt)
JP (1) JP2023520794A (pt)
KR (1) KR20230121960A (pt)
CN (1) CN116194431A (pt)
AU (1) AU2021248627A1 (pt)
BR (1) BR112022019616A2 (pt)
CA (1) CA3177186A1 (pt)
GB (2) GB2609814A (pt)
IL (1) IL296861A (pt)
MX (1) MX2022011832A (pt)
WO (1) WO2021198692A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022533484A (ja) * 2019-05-23 2022-07-22 カレ ケミカル テクノロジーズ インコーポレイテッド 触媒によるカンナビノイドプロセスおよび前駆体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007041167A2 (en) 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
DE102009019322A1 (de) 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US10059683B2 (en) 2015-07-10 2018-08-28 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
WO2017181118A1 (en) 2016-04-15 2017-10-19 Full Spectrum Laboratories Ltd Biosynthesis of cannabinoid prodrugs
CN109476625A (zh) 2016-06-16 2019-03-15 蒂温诺特技术有限公司 用于制备大麻素前药的方法、药物制剂及其用途
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
JP2020532590A (ja) 2017-09-01 2020-11-12 ピュアフォーム グローバル インコーポレイテッド 合成カンナビジオール組成物およびその製造方法
CN113164830B (zh) * 2018-08-20 2023-02-21 贝索制药有限责任公司 大麻素的制备方法
JP2022533484A (ja) * 2019-05-23 2022-07-22 カレ ケミカル テクノロジーズ インコーポレイテッド 触媒によるカンナビノイドプロセスおよび前駆体
JP2022547567A (ja) * 2019-09-09 2022-11-14 ケア ケミカル テクノロジーズ インコーポレイテッド カンナビノイド誘導体、前駆体、および使用
CA3150646A1 (en) * 2019-09-10 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRICAL SYNTHESIS THEREOF

Also Published As

Publication number Publication date
AU2021248627A1 (en) 2022-12-01
CA3177186A1 (en) 2021-10-07
CN116194431A (zh) 2023-05-30
US20230225985A1 (en) 2023-07-20
KR20230121960A (ko) 2023-08-22
EP4126800A1 (en) 2023-02-08
GB202104690D0 (en) 2021-05-12
GB202215746D0 (en) 2022-12-07
IL296861A (en) 2022-11-01
JP2023520794A (ja) 2023-05-19
GB2609814A (en) 2023-02-15
US20230227390A1 (en) 2023-07-20
MX2022011832A (es) 2023-03-03
GB2595355A (en) 2021-11-24
WO2021198692A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
GT200500307A (es) Compuestos quimicos
BRPI0415130A (pt) elemento de preensão, e, artigo
BR112022019616A2 (pt) Compostos terpenofenólicos e seu uso
BRPI0512065B8 (pt) artigo absorvente possuindo núcleo absorvente moldado formado sobre um substrato
EE05065B1 (et) Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
ATE220333T1 (de) Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin- sensitivität erhöht
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
CY1105349T1 (el) Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec
CL2008003854A1 (es) Compuestos derivados de 2-bencilpiridazinona, inhibidores, reguladores y/o moduladores de met-quinasa; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento de un tumor solido, de la sangre o del sistema inmune; kit farmaceutico que comprende una cantidad de dicho compuesto.
CL2021001325A1 (es) Ureas cíclicas.
BR0212944A (pt) N-(4-(4-metiltiazol-5-il)-pirimidin-2-il)-n-fenilaminas como compostos antiproliferativos
WO2002007600A3 (de) Prüfkörper und prüfkörpersysteme für nuklearmedizinische geräte und deren herstellung sowie verwendung
FI924166A (fi) Vattenbaserad, loesningsmedel- och emulgatorfri mikrobicid kombination av aktiva aemnen
BR9706386A (pt) Antagonistas do receptor de vitronectina, sua preparação e seu us0
MX9202544A (es) Compuestos de diaminoftalimidas substituidas y analogas, procedimiento para su preparacion y preparados farmaceuticos que los contienen.
BR9909679A (pt) Proteìna tao quinases e processos para seu uso
CL2000002938A1 (es) Cristales del acido (e)-4-[4-(5-metil-2-fenil-4-oxazolilmetoxi)benciloxiimino]-4-fenilbutirico, composicion farmaceutica que los comprende y su uso en el tratamiento o prevencion de la diabetes mellitus, hiperlipemia, disminucion en la tolerancia a la glucosa, enfermedades inflamatorias, arteriosclerosis.
BR0316500A (pt) N-alquinil-2-(fenóxi substituìdas)alquilamidas e seu uso como fungicidas
Yadav et al. Effects of fluconazole, chlorhexidine gluconate, and silver-zinc zeolite on flexural strength of heat-cured polymethyl methacrylate resin
ITMI920955A1 (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
ITMI911523A0 (it) Stabilizzante di materiali organici polimerici mediante l'impiego di miscele sinergiche costituite da ammine cicliche stericamente impedite e derivati del 3-pirazolidinone o del 1,2,4,-triazolidin-3,5,-dione
ATE353642T1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
PT1232188E (pt) Ciclodextrinas mono-substituidas a persubstituidas por grupos fluoralquilo, sua preparacao e sua utilizacao
BRPI0405376A (pt) Artigo absorvente descartável com barreiras externas colocadas para fora
ES2073381T3 (es) Procedimiento para la obtencion de granulados estructurados, hidrofobos, fluidos asi como utilizacion de los mismos.